Dan A. Landau

Dan A. Landau is a Scientific Advisor at Pangea Biomed. Dan was previously a postdoctoral fellow at Weill Cornell Medical College, the Broad Institute, and Dana-Farber Cancer Institute/Harvard Medical School. Dan completed their fellowship training in hematology and medical oncology at Yale University and Yale-New Haven Hospital. Dr. Landau also served as a tutor in history and physical examination at Yale University School of Medicine. Dan has been an editorial board member of the Leukemia Journal since 2014. Prior to their current position, Dr. Landau worked as a research associate at Pierre et Marie Curie University and as a medical officer in the Israeli Air Force.

Dan A. Landau received their Doctor of Philosophy (PhD) in Hematologic neoplasia from Université Denis Diderot (Paris VII) / University Paris VII. Dan then completed an Investigational Medicine PhD program at Yale University. After that, they completed an Internal Medicine Residency Program at Yale University. Dan also has a DIU in Immunulogy and cell therapy from Université Pierre et Marie Curie (Paris VI). Lastly, they received their Doctor of Medicine (MD) from Tel Aviv University. Dan also has a Bachelor of Science (BSc) in Medicine from Tel Aviv University.